The Consumer Justice Foundation Discusses the FDA’s Approval of Updated Labels for Diabetes Medication Actos

Share Article

The Consumer Justice Foundation, a team of consumer advocacy professionals who publish a free online resource regarding risks involved with medications at the URL http://www.SideEffectsRX.com, hereby discusses the approval by the Food and Drug Administration, or FDA, of updated labels for the diabetes medication known as Actos that details the risks of Actos side effects that could be encountered by some patients.

“Contact [a] healthcare professional [for] any sign of blood in the urine or a red color in the urine or other symptoms such as new or worsening urinary urgency or pain on urination since starting pioglitazone, as these may be due to bladder cancer.”

The Consumer Justice Foundation, an organization of consumer advocacy professionals who provide a free educational and informational resource for consumers regarding the potential dangers of different medications, hereby discusses the approval by the Food and Drug Administration, or the FDA, of updated labels for the diabetes medication that’s known as Actos. The containers of Actos will now clearly warn of the potential dangers of Actos side effects that could be encountered by some patients.

Specifically, Actos has been linked to the possibility of an increased risk for bladder cancer in those patients who have used this diabetes medication for more than one year. Actos has been banned in different countries in Europe and it came under FDA scrutiny for the alleged link between patients who have had a history of bladder cancer and the risk of developing the disease after using Actos to control diabetes.

The FDA approved the new label that’s been approved by the agency states that patients should, “Contact their healthcare professional if they experience any sign of blood in the urine or a red color in the urine or other symptoms such as new or worsening urinary urgency or pain on urination since starting pioglitazone, as these may be due to bladder cancer.”

The FDA also directed medical professionals that they should not use pioglitazone, the active ingredient in Actos, in patients with active bladder cancer. Medical professionals, according to the FDA, should also use pioglitazone with caution in patients with a prior history of bladder cancer. These steps should allow patients to minimize their risk of facing the development of Actos side effects.

About the Consumer Justice Foundation

The Consumer Justice Foundation, whose Web site can be found at http://www.consumerjusticefoundation.com, is a for-profit organization that serves two purposes for consumers: (1) to provide educational information regarding the policies and procedures of large corporations and how they affect the average consumer; and (2) to provide news updates and resources that continue to update consumers regarding developments taken by corporations that include pharmaceutical drug companies, auto manufacturers and insurance companies so that consumers who have been harmed can use these informational resources to connect to an experienced professional who can help them. The team at the Consumer Justice Foundation is staffed by experienced and passionate consumer advocates whose mission is to raise the awareness of issues that could pose a risk of harm to those who may not otherwise be aware of the dangers they face.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Faith Anderson
Visit website